After having suffered from a significant decline, the Second Sight Medical Products (NASDAQ: EYES) stock has gone into recovery mode.
This could well be the time for investors to start tracking the stock once again. The company is involved in providing solutions to people who might be suffering from different kinds of visual impairments. That being said, it seems that investors are still not yet convinced about the long-term prospects of the company. The stock has had a bit of a rollercoaster ride over the course of the past year.
At some points, the bulls have held sway while bears won the day at others. It was towards the end of 2020 that the stock really started showing signs of going on a strong rally after the bulls pushed it to $1.87 a share. Last month, the stock enjoyed a remarkable rally and eventually hit its highest levels in 52 weeks of $20 a share. However, the stock slumped to lower levels following a selloff. Investors could consider keeping the stock in their watch lists for now.